why choose us

First received: September 14, 2023

Clinical Trial: A Study of CT-868 in Type 1 Diabetes Mellitus

Study Status: Completed

Recruit Status: RECRUITING

Condition: Overweight

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of CT-868 Administered for 16 Weeks to Overweight and Obese Adult Par

Brief Summary: This study will evaluate the changes in glycemic control in overweight and obese adults with Type 1 Diabetes Mellitus after receiving CT-868 for 16 weeks.The effectiveness and safety of CT-868 will be compared to placebo.All participants will continue with their standard diabetes care using either an insulin pump (CSII) or multiple daily injections (MDI).Alongside their designated treatment, participants will receive guidance on managing their diabetes, including monitoring blood glucose levels and diet and…

Read more